Analyze Diet
Journal of analytical toxicology1999; 23(5); 372-379; doi: 10.1093/jat/23.5.372

Detection and identification of flunixin after multiple intravenous and intramuscular doses to horses.

Abstract: The objectives of the study were to compare various methods to determine flunixin in test samples collected periodically from horses after intramuscular (IM) and intravenous (IV) dosing at the maximum recommended dosage and to document detection times for this drug in test samples. Flunixin, a nonsteroidal anti-inflammatory drug approved for use in horses, was administered to eight mares in five consecutive daily doses of 1.1 mg per kilogram of body weight by the IM or IV route. Flunixin was detected in urine samples collected at various times after drug administration by flunixin enzyme-linked immunosorbent assay (ELISA), thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), and gas chromatographic-mass spectrometric (GC-MS) methods. Detection time was defined as the time period over which flunixin was detected and was dependent on the method used. The shortest detection times were 24 to 48 h and were observed when the TLC method was used. On the other hand, detection times were as long as 15 days when HPLC, GC-MS, and flunixin ELISA methods were used. The use of these more sensitive tests to monitor official samples collected from racehorses could result in positive tests for flunixin when it is exerting no detectable clinical effects because it produces clinical effects lasting only 24-36 h in horses.
Publication Date: 1999-09-17 PubMed ID: 10488926DOI: 10.1093/jat/23.5.372Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores different methods to test for the use of flunixin, an anti-inflammatory drug, in horses and compares the detection times using these methods. The findings reveal varying levels of effectiveness and detection durations between the different testing methods.

Objective of the Study

  • The study aimed at comparing different techniques used to detect the presence of Flunixin, a non-steroidal anti-inflammatory drug, in horses treated with this drug.
  • The motives extended to recording the detection periods—how long after administration the drug could be detected—using the various methods.
  • The drug was administered daily in recommended doses via both intramuscular (IM) and intravenous (IV) methods.

About Flunixin and its Administration

  • Flunixin is a non-steroidal anti-inflammatory drug that is officially approved for use in horses.
  • For this study, the drug was administered to eight mares at 1.1 mg per kilogram of their body weight over five consecutive days.
  • The dosages were delivered via both intravenous (IV) and intramuscular (IM) methods.

Detection Methods and Findings

  • Flunixin presence in the test samples was detected using four methods – enzyme-linked immunosorbent assay (ELISA), thin layer chromatography (TLC), high-performance liquid chromatography (HPLC), and gas chromatographic-mass spectrometric (GC-MS) methods.
  • Urine samples of the horses were collected at different intervals from the drug administration to be tested using these methods.
  • The detection time – the period in which Flunixin was detected – varied for each method.
  • The quickest detection times were between 24 to 48 hours, found when using the TLC method.
  • Longer detection periods of up to 15 days were observed with HPLC, GC-MS, and Flunixin ELISA methods.

Implications of the Findings

  • The results show that certain methods could result in long detection times that may flag a positive test for Flunixin use in racehorses even when the drug would not be having any clinical effects.
  • This is because Flunixin typically only produces clinical effects lasting 24-36 hours in horses, meaning even if the drug was detected after this period, it would not be impacting the animal’s racing performance.

Cite This Article

APA
Sams RA, Gerken DF, Ashcraft SM. (1999). Detection and identification of flunixin after multiple intravenous and intramuscular doses to horses. J Anal Toxicol, 23(5), 372-379. https://doi.org/10.1093/jat/23.5.372

Publication

ISSN: 0146-4760
NlmUniqueID: 7705085
Country: England
Language: English
Volume: 23
Issue: 5
Pages: 372-379

Researcher Affiliations

Sams, R A
  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus 43210, USA.
Gerken, D F
    Ashcraft, S M

      MeSH Terms

      • Animals
      • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
      • Anti-Inflammatory Agents, Non-Steroidal / chemistry
      • Anti-Inflammatory Agents, Non-Steroidal / urine
      • Chromatography, High Pressure Liquid
      • Chromatography, Thin Layer
      • Clonixin / administration & dosage
      • Clonixin / analogs & derivatives
      • Clonixin / chemistry
      • Clonixin / urine
      • Enzyme-Linked Immunosorbent Assay
      • Female
      • Gas Chromatography-Mass Spectrometry
      • Horses / urine
      • Injections, Intramuscular
      • Injections, Intravenous
      • Sensitivity and Specificity
      • Substance Abuse Detection / methods

      Citations

      This article has been cited 3 times.
      1. Kuroda T, Minamijima Y, Nomura M, Yamashita S, Yamada M, Nagata S, Mita H, Tamura N, Fukuda K, Kuwano A, Kusano K, Toutain PL, Sato F. Medication control of flunixin in racing horses: Possible detection times using Monte Carlo simulations. Equine Vet J 2022 Sep;54(5):979-988.
        doi: 10.1111/evj.13532pubmed: 34719043google scholar: lookup
      2. Knych HK, Finno CJ, Baden R, Arthur RM, McKemie DS. Identification and characterization of the enzymes responsible for the metabolism of the non-steroidal anti-inflammatory drugs, flunixin meglumine and phenylbutazone, in horses. J Vet Pharmacol Ther 2021 Jan;44(1):36-46.
        doi: 10.1111/jvp.12891pubmed: 32757313google scholar: lookup
      3. Kuroda T, Knych HK, Noble GK, Minamijima Y, Leung GN, Nomura M, Mizobe F, Ishikawa Y, Kusano K, Toutain PL. A Meta-Analysis of International Flunixin Pharmacokinetics in Horses: Toward Regulatory Harmonization and Individualized Detection Times Using Bayesian Paradigm. Drug Test Anal 2026 Jan;18(1):32-50.
        doi: 10.1002/dta.3961pubmed: 41137541google scholar: lookup